Skip to main content

Table 1 Baseline characteristics for 447 patients whose status at the end of the study period is known

From: Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts

Baseline characteristic/Outcome Total (N = 447) n, %
Months on effective regimen (mean, sd) 11.6 (7.9)
Ever on effective regimen 369 (82.6)
Sociodemographic characteristics
 Age, years (mean, sd) 35.9 (11.4)
 Female sex 84 (18.8)
 Married (n = 434) 200 (46.1)
 Unemployed (n = 445) 352 (79.1)
 Current or previous incarceration 237 (53.0)
 Alcohol abuse/dependence 194 (43.4)
 Illicit drug use 79 (17.7)
 Homelessness 16 (3.6)
Comorbidities
 HIV-positive (n = 446) 3 (0.7)
 Diabetes mellitus (n = 446) 18 (4.0)
 Comorbid condition 322 (72.0)
Prior TB treatment exposure
 Previously treated for TB 444 (99.3)
 History of prior injectable exposure (n = 436) 145 (33.3)
 History of prior fluoroquinolone exposure (n = 436) 69 (15.8)
 History of prior default 16 (3.6)
 Number of previous TB treatments (mean, sd) 2.1 (1.2)
 > 2 previous TB treatment (n = 436) 141 (32.3)
Clinical indications of disease severity
 Bilateral and cavitary disease on baseline chest x-ray (n = 443) 278 (62.8)
 Severe pulmonary disease on baseline chest x-ray 195 (43.6)
 Low BMI at start of treatment (n = 446) 190 (42.6)
 Severe baseline clinical status 277 (62.0)
 Extrapulmonary disease (n = 381) 39 (10.2)
 Previous TB-related surgery (n = 445) 50 (11.2)
 Baseline XDR-TB 22 (4.9)
Initial treatment outcome
 Successful 299 (66.9)
 Cure 280 (62.6)
 Treatment Completion 19 (4.3)
 Unsuccessful 148 (33.1)
 Death 30 (6.7)
 Treatment Failure 39 (8.7)
 Default 78 (17.4)
 Transfer Out 1 (0.2)